Intellia Therapeutics Inc (NTLA) Dividend History
Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and Virginijus Šikšnys . The company has partnerships with Novartis and Regeneron. Intellia Therapeutics was founded in May 2014 to develop biopharmaceuticals using CRISPR.
Last update 02/03/2023
Dividend Yield Summary
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 24.12 | 15.12 | 21.99 | 105.98 | 61.22 | 37.40 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |